<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang D</submitter><funding>China Agriculture Research System of MOF and MARA</funding><funding>National Key Research and Development Program of China</funding><pagination>1800</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9495437</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(9)</volume><pubmed_abstract>A 7-week rearing trial was designed to investigate the effects of Eucommia ulmoides leaf extract (ELE) on growth performance, body composition, antioxidant capacity, immune response, and disease susceptibility of diet-fed GIFT. The results showed that dietary ELE did not affect growth performance or whole-body composition (p > 0.05). Compared with the control group, plasma ALB contents increased in the 0.06% dietary ELE group (p &lt; 0.05), and plasma ALT and AST activities decreased in the 0.08% dietary ELE group (p &lt; 0.05). In terms of antioxidants, compared with GIFT fed the control diet, 0.06% dietary ELE upregulated the mRNA expression levels of Nrf2 pathway-related antioxidant genes, including CAT and SOD (p &lt; 0.05), and 0.06% and 0.08% dietary ELE upregulated the mRNA levels of Hsp70 (p &lt; 0.05). In terms of immunity, 0.06% dietary ELE suppressed intestinal TLR2, MyD88, and NF-κB mRNA levels (p &lt; 0.05). Moreover, the mRNA levels of the anti-inflammatory cytokines TGF-β and IL-10 were upregulated by supplementation with 0.04% and 0.06% dietary ELE (p &lt; 0.05). In terms of apoptosis, 0.06% and 0.08% ELE significantly downregulated the expression levels of FADD mRNA (p &lt; 0.05). Finally, the challenge experiment with S. agalactiae showed that 0.06% dietary ELE could inhibit bacterial infection, and significantly improve the survival rate of GIFT (p &lt; 0.05). This study demonstrated that the supplementation of 0.04−0.06% ELE in diet could promote intestinal antioxidant capacity, enhance the immune response and ultimately improve the disease resistance of GIFT against Streptococcus agalactiae.</pubmed_abstract><journal>Antioxidants (Basel, Switzerland)</journal><pubmed_title>Dietary Supplementation with &lt;i>Eucommia ulmoides&lt;/i> Leaf Extract Improved the Intestinal Antioxidant Capacity, Immune Response, and Disease Resistance against &lt;i>Streptococcus agalactiae&lt;/i> in Genetically Improved Farmed Tilapia (GIFT; &lt;i>Oreochromis niloticus&lt;/i>).</pubmed_title><pmcid>PMC9495437</pmcid><funding_grant_id>CARS-46</funding_grant_id><funding_grant_id>2018YFD0900400</funding_grant_id><pubmed_authors>Huang D</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Ge X</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Ren M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dietary Supplementation with &lt;i>Eucommia ulmoides&lt;/i> Leaf Extract Improved the Intestinal Antioxidant Capacity, Immune Response, and Disease Resistance against &lt;i>Streptococcus agalactiae&lt;/i> in Genetically Improved Farmed Tilapia (GIFT; &lt;i>Oreochromis niloticus&lt;/i>).</name><description>A 7-week rearing trial was designed to investigate the effects of Eucommia ulmoides leaf extract (ELE) on growth performance, body composition, antioxidant capacity, immune response, and disease susceptibility of diet-fed GIFT. The results showed that dietary ELE did not affect growth performance or whole-body composition (p > 0.05). Compared with the control group, plasma ALB contents increased in the 0.06% dietary ELE group (p &lt; 0.05), and plasma ALT and AST activities decreased in the 0.08% dietary ELE group (p &lt; 0.05). In terms of antioxidants, compared with GIFT fed the control diet, 0.06% dietary ELE upregulated the mRNA expression levels of Nrf2 pathway-related antioxidant genes, including CAT and SOD (p &lt; 0.05), and 0.06% and 0.08% dietary ELE upregulated the mRNA levels of Hsp70 (p &lt; 0.05). In terms of immunity, 0.06% dietary ELE suppressed intestinal TLR2, MyD88, and NF-κB mRNA levels (p &lt; 0.05). Moreover, the mRNA levels of the anti-inflammatory cytokines TGF-β and IL-10 were upregulated by supplementation with 0.04% and 0.06% dietary ELE (p &lt; 0.05). In terms of apoptosis, 0.06% and 0.08% ELE significantly downregulated the expression levels of FADD mRNA (p &lt; 0.05). Finally, the challenge experiment with S. agalactiae showed that 0.06% dietary ELE could inhibit bacterial infection, and significantly improve the survival rate of GIFT (p &lt; 0.05). This study demonstrated that the supplementation of 0.04−0.06% ELE in diet could promote intestinal antioxidant capacity, enhance the immune response and ultimately improve the disease resistance of GIFT against Streptococcus agalactiae.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-05-31T23:13:37.761Z</modification><creation>2024-11-12T02:34:26.121Z</creation></dates><accession>S-EPMC9495437</accession><cross_references><pubmed>36139874</pubmed><doi>10.3390/antiox11091800</doi></cross_references></HashMap>